CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 55,000 shares at $1.69 ($92,730)
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 10-K/A Report 10-K/A
- 4 Shares withheld for taxes President and CEO gave up 20,631 shares (to pay taxes)
- 4 Option exercise EVP, President US acquired 16,333 shares (option exercise)
- 4 Shares withheld for taxes SVP and CFO gave up 6,213 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,508 shares (to pay taxes)
Page 16 of 77 · 1,527 filings